Teva received FDA approval for WELTRUZA, a once-monthly subcutaneous olanzapine injection for adults with schizophrenia, with ...

Humana shares jumped 14.4% to $443 after 95% of members were shown in Medicare Advantage plans rated four stars or higher for ...

Michael Hurlston, CEO of Lumentum, says the optoelectronic products his company produces for AI infrastructure projects are ...

Seema Shah, Chief Global Strategist at Principal Global Investors, discusses the AI capex cycle and the impact on investor ...

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...

Aura Minerals reported record Q3 2026 production of 95,557 gold equivalent ounces, up 29% year over year, with sales reaching ...

Pebblebrook Hotel Trust sold the 174-room Hotel Zags in Portland for $10 million after the property recorded estimated ...

Col. Wayne Sanders (Ret.) of Bloomberg Intelligence examines what he calls the "hornet's nest" of increased activity in the ...

Chris Verrone, partner and chief market strategist at Baird Strategas, sees equity markets as "highly rotational" and doesn't ...

Seaport Therapeutics reported Phase 1 GlyphAgo data showing 6.8-fold higher agomelatine bioavailability and substantially ...

Sagimet reported 52-week denifanstat acne data showing 57% IGA success, 72% lower total lesions and 77% fewer inflammatory ...

Arcutis reported ZORYVE data showing 34.4% infant skin clearance in atopic dermatitis and stronger Week 8 psoriasis responses ...